Infants Pain and Fever Acetaminophen recalled for contaminated excipient
Perrigo Company is recalling Infants Pain and Fever Acetaminophen Infant Dye Free Grape Oral Suspension due to contaminated excipient used in manufacturing. The recall affects 1,296 bottles distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a manufacturing deviation (contaminated excipient). The source text does not report any illnesses, injuries, or deaths. The hazard is based on a manufacturing process defect rather than confirmed product contamination or harm.
Plain-English summary
Perrigo Company PLC is recalling Infants Pain and Fever Acetaminophen Infant Dye Free Grape Oral Suspension, 160mg/5ml, 2 FL OZ (59 mL) bottles (NDC: 30142-766-16) distributed by The Kroger Co. The recall involves 1,296 bottles nationwide due to current good manufacturing practice (CGMP) deviations during manufacturing. The product was manufactured using a contaminated excipient that had been recalled from the excipient supplier. Consumers who have purchased this product should stop using it and consult a healthcare provider if they have questions or concerns.
The recalled product
- Product
- INFANTS PAIN AND FEVER (ACETAMINOPHEN)
- Brand
- INFANTS PAIN AND FEVER
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Pediatric Oral Suspension
- Hazard
- contaminated-excipient
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1CK1274
- Exp 02/28/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · INFANTS PAIN AND FEVER
- HighKinderFarms Infants' Acetaminophen Recalled for Failed Impurity and Degradation Standards
FDA (Drugs) · 2023-12-13
- ModerateInfants Pain and Fever acetaminophen recalled for contaminated excipient
FDA (Drugs) · 2022-03-02
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27